JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Ophthalmology Section DOI : 10.7860/JCDR/2018/34541.11620
Year : 2018 | Month : Jun | Volume : 12 | Issue : 6 Full Version Page : NC05 - NC08

Reliability of Visual Field Index in Staging Glaucomatous Visual Field Damage

Neetha Kuzhuppilly1, Shilpa Patil2, Shibi Dev3, Aditya Deo4

1 Assistant Professor, Department of Ophthalmology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Udupi, Karnataka, India.
2 Glaucoma Consultant, Department of Glaucoma, Aastha Superspeciality Eye Hospital, Bengaluru, Karnataka, India.
3 Head of Department, Department of Glaucoma, Nethradhama Superspeciality Eye Hospital, Bengaluru, Karnataka, India.
4 Consultant Ophthalmologist and Glaucoma Surgeon, Department of Ophthalmology, Eye Infirmary and Laser Centre, Nagpur, Maharashtra, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Neetha Kuzhuppilly Assistant Professor, Department of Ophthalmology, Kasturba Medical College, Manipal, Udupi, Karnataka, India.
E-mail: cinnineetha@gmail.com
Abstract

Introduction

Standard automated perimetry is integral to the testing of visual function in glaucoma. Classification of glaucomatous visual field defects into different severity levels is important to guide effective management; but the available classification systems may be cumbersome and impractical on a daily basis.

Aim

To quantify, correlate and analyse the relation between Visual Field Index (VFI) and the stages of glaucomatous field damage as defined by Hodapp Parrish Anderson (HPA). To check the validity of Glaucoma Staging Indices (GSI), which is a new glaucomatous field classification system dependent on VFI.

Materials and Methods

The study was a prospective, observational analysis of condivutive visual field tests done between August 2015 and March 2016. The Institutional Ethical Committee approved the protocol, and participants who gave written informed consent were included in the study. Patients underwent a comprehensive eye examination including standard automated perimetry with Humphrey Visual Field Analyser. Data was collected from each visual field and the fields were evaluated and classified into four stages- Normal, Early defect, Moderate defect or Severe defect based on HPA classification. HPA and Geological Strength Index (GSI) classification systems were compared and analysed with Kappa analysis.

Results

Analysis of 170 visual fields of 95 patients showed that VFI was significantly different between Normal, Early defect, Moderate defect and Severe defects as classified with HPA staging, p<0.001. VFI had strong positive correlation with Mean Deviation (MD), r=0.984, p<0.001 and non-linear correlation with Pattern Standard Deviation (PSD), r = -0.472, p<0.001.

On comparing HPA staging with GSI, κ=0.633, p<0.001. VFI, MD and PSD in each of the severity stages across the two classification systems showed no significant differences (p>0.05).

Conclusion

In established glaucoma, GSI is a good dependable staging system. It is readily available on the single field print out and can be a quick reference for decision making in the management of glaucoma patients.

Keywords

Introduction

Standard automated perimetry is integral to the testing of visual function in glaucoma. In the initial tests, it detects and quantifies damage, and in follow-up of a diagnosed patient, it detects stability or progression of glaucomatous damage [1].

Classification of glaucomatous visual field defects and staging its severity is important for effective glaucoma management. This classification is utilized to distinguish between healthy and glaucomatous individuals, to adjust therapy on the basis of disease severity, to describe visual field conditions in a short and simple format, to monitor the progression of the disease, and to provide a common language for both clinical and research purposes [2]. More than 20 severity classification methods have been proposed since 1958 [3].

The staging systems commonly used in research are HPA classification, The Glaucoma Severity Staging System (GSS: this is HPA classification which has been modified by Mills RP et al.,), the Enhanced Glaucoma Severity Staging System (eGSS), the Advanced Glaucoma Intervention Study scoring system (AGIS) [2,4]. The classification systems used in research may be cumbersome and impractical on a daily basis in a busy glaucoma/ophthalmic practice. Availability of a simpler staging system is the need of the hour.

GSI has been introduced in the Humphrey Visual Field single field analysis reports. It is the visual field staging system devised by Vessani RM and Susanna R, at University of São Paulo, Brazil [1,5]. This is a staging system readily available on the print out and is dependent on the VFI to stage the fields into Early, Moderate or Severe damage.

Visual Field Index is a global index developed by Bengtsson and Heijl in 2008 as a new index intended to be less affected by cataract than the Mean Deviation (MD) [6]. It is expressed as a percentage of visual function; with 100% being a perfect age-adjusted visual field and 0% represents a perimetrically blind field. The pattern deviation probability plot (or total deviation probability plot when MD is worse than -20dB) is used to identify abnormal points and age corrected sensitivity at each point is calculated using total deviation numerical map. The central points are given more weightage and the mean of all points is expressed as a percentage i.e., the VFI.

The staging systems till date depend on analysis of various factors like Mean Deviation (MD), Pattern Standard Deviation (PSD), involvement of the central field, number and depth of depressed points on total or pattern deviation plots etc., [2]. The study aims to determine if VFI alone can be depended upon when staging a visual field, as seen in the GSI classification system. The study uses HPA staging for visual field tests comparing it with GSI based classification.

Materials and Methods

The study was a prospective, observational analysis of consecutive visual field tests done between August 2015 and March 2016 at the Glaucoma clinic of a tertiary eye care hospital. In accordance with the Declaration of Helsinki, the Ethics Review Board of the Institution approved the protocol, and visual fields of only those participants who gave written informed consent were included in the study. Patients underwent a comprehensive eye examination including visual acuity measurement, slit lamp evaluation, Intra Ocular Pressure (IOP) measurement, stereoscopic fundus evaluation and visual field evaluation. All participants underwent standard automated perimetry (Humphrey Visual Field Analyser II-i750-8786/5.0 and 745-40053/5.1.1, Carl Zeiss Meditec, Inc., Dublin, CA) using central 30-2 program and the standard Swedish Interactive Threshold Algorithm. Visual fields of all patients were included irrespective of their glaucoma diagnosis.

Visual fields were excluded from analysis if the participants had a history of intraocular surgery other than uncomplicated cataract, glaucoma or combined surgery, or if they had secondary causes of elevated IOP (e.g., iridocyclitis, trauma), other intraocular diseases affecting the visual field (e.g., retinal diseases/lesions), medications known to affect visual field sensitivity, neurological causes of visual field defects. All visual fields with poor reliability were also excluded from analysis. (Reliability was defined as less than 20% fixation losses and less than 33% for both false-positive and false-negative errors) [7].

Data was collected from each visual field which included the MD, Pattern Standard Deviation (PSD), Visual Field Index and also patient demographic details. Each visual field was graded using HPA classification system into four stages- Normal, Early defect, Moderate defect or Severe defect [8]

Staging of visual fields in GSI was noted from the visual fields [1,5]. This staging is readily available on the visual field printout and does not require additional calculations. The GSI Staging System is divided into three parts. The first part defines the visual field defect as Early (E), Moderate (M) or Severe (S) according to VFI. The second part reports if the defect is located outside 10 degrees of the visual field (10+), between 5 and 10 degrees (10) or inside 5 degrees of the visual field (5). The third part describes if the visual field defect is located in only one hemifield (1) or in both hemifields (2) and if it connects to the blind spot (B) or not (A) depending on points depressed below 0.5% level on the pattern deviation probability plot. For example, E96/10+/1A would mean an Early defect with VFI 96%, with visual field defect outside the central 10 degrees, with one hemifield involvement which is not connected to the blind spot.

Statistical Analysis

All statistical analyses were done with SPSS (IBM Corp. IBM SPSS Statistics for Windows, Version 22.0.). From a pilot study it was determined that 18 visual fields were adequate in each of the severity groups for 90% Power of the study with confidence interval 95%. Independent t-test was used for comparison of means between groups and ANOVA for comparison between multiple groups. Correlation analysis determined relationship between global indices. Kappa statistical analysis was conducted to determine the degree of agreement between two classification systems. A p-value less than 0.05 were taken as statistically significant.

Results

One hundred and seventy visual fields of 95 patients were included in the study. Forty patients were women (42.1%) and 55 were men (57.9%). The mean age of all the participants was 65.95±14.06 years.

Based on HPA classification of visual field damage, the Normal group had 41 eyes, the Early defect group 30, the Moderate defect group 36, and the Severe defect group 63. The VFI compared between groups using ANOVA was seen to be significantly different (p<0.001). On comparison of mean VFI values between Normal and Early groups, Early and Moderate groups, Moderate and Severe groups, all were seen to be statistically significantly different at p<0.001.

[Table/Fig-1] depicts the Mean±standard deviation of VFI, MD and PSD among the groups and their significance. It was determined that the MD and PSD were also significantly different among the groups, using ANOVA.

Mean Visual Field Index (VFI), Mean Deviation (MD) and Pattern Standard Deviation (PSD) among the groups as per Hodapp Parrish Anderson (HPA) classification.

ParametersNormalEarly DefectModerate DefectSevere Defectp-value
VFI98.49±1.8694.63±2.9584.08±7.2347.44±25.82p<0.001
MD-0.89±1.59-2.96±1.56-6.61±2.31-17.70±7.95p<0.001
PSD2.53±1.094.91±2.077.99±2.4210.36±3.38p<0.001

Overall a strong positive correlation was found between VFI and MD with Pearson correlation coefficient (r) being 0.984 (p<0.001) [Table/Fig-2]. Good correlations between VFI and MD were found in groups with Normal, Early or Moderate defects (r-values being 0.743, 0.703 and 0.695 respectively) and excellent positive correlation was seen in the group with severe visual field defect (r = 0.977).

Correlating VFI with MD, r=0.984, p<0.001.

MD: Mean deviation

A significant negative non-linear correlation was seen between VFI and PSD (r=-0.472, p<0.001) [Table/Fig-3]. On further analysis of VFI with PSD within individual groups, it was seen that the group with moderate visual field defect showed a strong negative correlation with r= -0.777, the Normal and Early defect groups showed average negative correlations of r-values of -0.682 and -0.483 (p= 0.007) respectively. The severe defect group showed a positive correlation of r-value 0.504. All except early group showed significant correlation at p<0.001.

Correlating VFI with PSD, r= -0.472, p<0.001.

PSD: Pattern standard deviationwith

Using the Glaucoma Staging Indices, the fields were graded into “Normal” in 26 eyes, “Early defect” in 45 eyes, “Moderate defect” in 39 eyes and “Severe defect” in 60 eyes. There exists a strong agreement between HPA and GSI staging systems as seen by a Kappa value of 0.633, p<0.001.

From [Table/Fig-4], it is seen that some amount of overlap of cases exist between the two classification systems. The 15 of visual fields classified as Early defect by GSI were Normal by HPA classification [Table/Fig-5]. Similarly among those classified as Moderate defect by GSI, 11 had severe defect on HPA classification. Eight of those classified as Severe defect by GSI had Moderate defect in HPA classification.

Comparison between Hodapp Parrish Anderson (HPA) and Glaucoma Staging Indices (GSI) classification systems, κ =0.633, p<0.001.

GSI classificationTotal
NormalEarlyModerateSevere
HPA StagingNormal26150041
Early Defect0246030
Moderate Defect0622836
Severe Defect00115263
Total26453960170

Visual field showing zero sensitivity in the central five degrees of the field and hence classified as a severe defect by HPA classification but is a moderate defect based on GSI classification.

Comparison of VFI across severity stages between the two classification systems.

Comparison of MD across severity stages between the two classification systems.

Comparison of Pattern Standard Deviation (PSD) across severity stages between the two classification systems.

We compared the VFI, MD and PSD for visual fields in each of the severity stages across the two classification systems. Using Independent samples t-test it was found that there were no significant differences in any of the global indices (p>0.05) within each severity group, between HPA and GSI classifications. This is evident from [Table/Fig-6,7 and 8].

Discussion

Of the various visual field classification systems, the HPA is most commonly used in clinical studies [2]. HPA is time consuming and needs analysis of individual fields, whereas GSI is readily available on the single field printout. GSI depends on VFI to make the distinctions between groups of varying visual field damage severity. In the present study we sought to evaluate the agreement between these two staging systems.

In the initial part of present study, we analyzed the VFI values in each of the stages of visual field damage as classified by HPA. VFI values were found to be significantly different in each of the glaucoma severity groups. No studies in current literature have established the significant difference of VFI in different stages of glaucomatous field damage [2,3]. Even though an overlap of VFI values were seen across different stages, it was not statistically significant.

On further analysis it was seen that VFI correlated well, in a positive linear fashion with MD. This correlation was greatest in the severe stage compared to the other stages. We also noted that there were 13 eyes with VFI of 100% and the MD of these eyes ranged widely from 1.88 to -1.14dB. This is possibly due to the ceiling effect of VFI noted in near normal studies and has been previously reported [9,10]. This advises us to exercise caution when trying to differentiate early glaucomatous fields from normal.

In the study by Artes HP et al., it was seen that in eyes with MD better that -5dB, the VFI was close to 100% and suggested that VFI may underestimate the rate of change in eyes with initially normal visual fields that are developing glaucomatous damage [9]. Marvasti AH et al., have reported that the relationship between VFI and estimated retinal ganglion cell counts is nonlinear and the index substantially underestimates the amount of neural loss early in the disease [11].

PSD is known to increase in the initial stages of glaucoma as visual field damage worsens, but after reaching a certain point where there is severe damage and generalized involvement of the visual field, the PSD once again starts decreasing [10]. As expected, in our study, VFI correlates negatively with the PSD in the initial stages of glaucoma and as the visual field damage advances, a positive correlation is seen in the severe stages of glaucoma.

Overall, with these findings we were able to establish that VFI agreed well with the HPA classification system and was a dependable variable to base a visual field severity staging on, except in normal/early cases.

In the present study it was seen that there is a large amount of overlap of VFI values at each adjacent HPA staging group. Vessani RM and Susanna R, had taken this into consideration and preferring to err on the side of classifying a field defect as more severe than less, the higher limits of VFI in each group were taken as cut off points [5]. The cut off for VFI between severe and moderate stages was 78%, between moderate and early was 91%. Significantly, they did not devise a cut-off point between early and normal visual fields. This accounts for the remarkable number of eyes staged as Early defect by GSI staging, and were found to be Normal by the HPA classification (15 eyes i.e., 33%).

In the present study, 11 out of 39 (28.2%) fields classified to be moderate by GSI, had severe defect on HPA classification. Nine of these 11 eyes had VFI ranging from 78%-81%. In the present study, on classifying the visual fields based on HPA staging, showed that the 95th percentile VFI values were 81%, 93.3% and 98.45% for the Severe, Moderate and Early stages respectively. This suggests GSI underestimates the visual field defect in comparison to HPA. And the remaining two severe cases under-classified as moderate by GSI, they had VFI of 85% but had points with zero sensitivity in the central five degrees of the field [Table/Fig-3]. Classification of fields based on VFI alone is likely to miss out on early central field depressions. GSI overcomes this pitfall with the second part of its scale where a mention is made about the degree of central field involvement.

Comparison of global indices at all stages between HPA and GSI staging systems did not show any significant difference. Ng M et al., have compared global indices between AGIS, eGSS and GSS; and found that only AGIS and eGSS were comparable [3]. In the present study, all indices including VFI values were comparable between HPA and GSI systems. Till date, no study has made this comparison between these two classification systems.

When compared to GSI classification system, HPA is time consuming and needs analysis of individual fields. HPA with its broad classifications may not be appropriate for analysing stability or progression over time, whereas GSI includes the VFI which can be utilized for progression evaluation [12]. HPA takes into account number and depth of defective points and its relation to fixation but GSI gives additional information about the location of the defect and its relation to the blind spot [1,5].

It is established that with higher severity of visual field defect, the disability increases [13,14]. As per HPA even a single point in central five degrees with 0dB sensitivity is classified as a severe defect, but this may not have a greater vision related disability for the patient. This needs to be evaluated in future studies wherein quality of vision and life or activity limitation can be evaluated with regard to VFI and visual field grading systems [15,16]. If the HPA staging is overestimating the severity in such cases, GSI may be a more relevant classification.

VFI is a reliable index on which glaucomatous visual field severity staging can be based. In the early stages of the disease, it is fallacious to depend on VFI to make a diagnosis of glaucoma, and it is still left to the treating doctor to make a clinical judgement. In the latter stages, GSI tends to underestimate the severity of visual field defect with reference to HPA classification system. Overall, once glaucoma has been established, GSI is a good dependable glaucoma severity staging system. It is readily available on the single field print out and can be a quick reference for decision making in the management of glaucoma patients.

Limitation

One drawback of the study is that there is no single established gold standard for grading visual fields and we have studied GSI with reference to only one classification system. Additionally, this being a cross sectional study, we have not assessed change with time using these classification systems. A limitation that may be faced is that the GSI classification may not be printed on the single field report, when test is done on a machine without the required software.

Conclusion

VFI is reliable in staging visual field damage except in early stages of glaucoma. GSI is a dependable visual field severity staging system once a clinical diagnosis of glaucoma is established.

References

[1]Susanna R, Vessani RM, Staging glaucoma patient: why and how? Open Ophthalmol J 2009 3:59-64.10.2174/187436410090302005919834563  [Google Scholar]  [CrossRef]  [PubMed]

[2]Brusini P, Johnson CA, Staging functional damage in glaucoma: review of different classification methods Surv Ophthalmol 2007 52(2):156-79.10.1016/j.survophthal.2006.12.00817355855  [Google Scholar]  [CrossRef]  [PubMed]

[3]Ng M, Sample PA, Pascual JP, Zangwill LM, Girkin CA, Liebmann JM, Comparison of visual field severity classification systems for Glaucoma J Glaucoma 2012 21(8):551-61.10.1097/IJG.0b013e31821dac6621878817  [Google Scholar]  [CrossRef]  [PubMed]

[4]Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease Am J Ophthalmol 2006 141(1):24-30.10.1016/j.ajo.2005.07.04416386972  [Google Scholar]  [CrossRef]  [PubMed]

[5]Vessani RM, Susanna R, University of São Paulo Glaucoma Visual Field Staging System (USP-GVFSS): A New Way to Stage Visual Field in Glaucoma [Abstract] Invest Ophthalmol Vis Sci 2009 50:5287  [Google Scholar]

[6]Bengtsson B, Heijl A, A visual field index for calculation of glaucoma rate of progression Am J Ophthalmol 2008 145(2):343-53.10.1016/j.ajo.2007.09.03818078852  [Google Scholar]  [CrossRef]  [PubMed]

[7]Newkirk MR, Gardiner SK, Demirel S, Johnson CA, Assessment of false positives with the Humphrey Field Analyser II perimeter with the SITA Algorithm Invest Ophthalmol Vis Sci 2006 47(10):4632-37.10.1167/iovs.05-159817003461  [Google Scholar]  [CrossRef]  [PubMed]

[8]Hodapp E, Parrish RK III, Anderson DR, Clinical decisions in glaucoma 1993 St. LouisThe CV Mosby Co:52-61.  [Google Scholar]

[9]Artes HP, O’Leary N, Hutchison DM, Heckler L, Sharpe GP, Nicolela MT, Properties of the Statpac Visual Field Index Invest Ophthalmol Vis Sci 2011 52(7):4030-38.10.1167/iovs.10-690521467169  [Google Scholar]  [CrossRef]  [PubMed]

[10]Sousa MCC, Biteli LG, Dorairaj S, Maslin JS, Leite MT, Prata ST, Suitability of the visual field index according to glaucoma severity J Curr Glaucoma Pract 2015 9(3):65-68.10.5005/jp-journals-10008-118626997838  [Google Scholar]  [CrossRef]  [PubMed]

[11]Marvasti AH, Tatham AJ, Zangwill LM, Girkin CA, Liebmann JM, Weinreb RN, The relationship between visual field index and estimated number of retinal ganglion cells in glaucoma PLoS One 2013 8(10):e7659010.1371/journal.pone.007659024146895  [Google Scholar]  [CrossRef]  [PubMed]

[12]Medeiros FA, Weinreb RN, Moore G, Liebmann JM, Girkin CA, Zangwill LM, Integrating event- and trend-based analyses to improve detection of glaucomatous visual field progression Ophthalmology 2012 119(3):458-67.10.1016/j.ophtha.2011.10.00322266109  [Google Scholar]  [CrossRef]  [PubMed]

[13]Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C, Quality of life in glaucoma and its relationship with visual function J Glaucoma 2003 12(2):139-50.10.1097/00061198-200304000-0000912671469  [Google Scholar]  [CrossRef]  [PubMed]

[14]Peters D, Heijl A, Brenner L, Bengtsson B, Visual impairment and vision related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow up Acta Ophthalmol 2015 93(8):745-52.10.1111/aos.1283926382936  [Google Scholar]  [CrossRef]  [PubMed]

[15]van Gestel A, Webers CA, Beckers HJ, van Dongen MC, Severens JL, Hendrikse F, The relationship between visual field loss in glaucoma and health-related quality-of-life Eye (Lond) 2010 24(12):1759-69.10.1038/eye.2010.13321057519  [Google Scholar]  [CrossRef]  [PubMed]

[16]Khadka J, Pesudovs K, McAlinden C, Vogel M, Kernt M, Hirneiss C, Reengineering the glaucoma quality of life-15 questionnaire with Rasch analysis Invest Ophthalmol Vis Sci 2011 52(9):6971-77.10.1167/iovs.11-742321810983  [Google Scholar]  [CrossRef]  [PubMed]